Protia Inc.
Research Protia Inc. (303360.KQ) on Bullrun: market cap KRW 74.19B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker303360.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyKRW
- Market capKRW 74.19B
- Financial periodQ2 2026
- RevenueKRW 5.35B
- Net incomeKRW 1.55B
- Free cash flowKRW 1.05B
- Gross margin61.2%
Valuation Snapshot
latest market cap is KRW 74.19B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 74.19B | n/a | n/a | n/a |
Dividend history
About Protia Inc.
Protia Inc. manufactures and sells in vitro diagnostic medical devices in South Korea. It offers allergy, animal diagnosis, autoimmune, antibiotic susceptibility, POCT, cancer, and related instrument products, as well as protein analysis, LC-MS/MS, characterization analysis, and custom protein services. The company was formerly known as ProteomeTech Inc. and changed its name to Protia Inc. in November 2023. Protia Inc. was founded in 2000 and is headquartered in Seoul, South Korea.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Protia Inc.'s market cap?
Protia Inc.'s market capitalization is KRW 74.19B.
What does Protia Inc. do?
Protia Inc. manufactures and sells in vitro diagnostic medical devices in South Korea. It offers allergy, animal diagnosis, autoimmune, antibiotic susceptibility, POCT, cancer, and related instrument products, as well as protein analysis, LC-MS/MS, characterization analysis, and custom protein services. The company was formerly known as ProteomeTech Inc. and changed its name to Protia Inc. in November 2023. Protia Inc. was founded in 2000 and is headquartered in Seoul, South Korea.